Thermo Fisher Scientific - Company Intelligence Profile
Industry: Biotechnology Research | Founded: not publicly disclosed | HQ: Waltham, United States
About Thermo Fisher Scientific
Datakart tracks firmographic, hiring, traffic, technology, funding, review, and leadership signals for Thermo Fisher Scientific to help teams evaluate the account with useful business context.
Public Company
Thermo Fisher Scientific
thermofisher.com
Employees
99.9K
Monthly visits
5.6M
Open roles
3.8K
Search volume
33.1K
Company Snapshot
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
For more information, please visit www.thermofisher.com.
Founded
Employee count
Monthly website visits
Open roles
Company Snapshot Details
Business signals that help qualify Thermo Fisher Scientific
This profile combines firmographic, traffic, hiring, employee, review, compensation, technology, funding, leadership, and product availability signals so visitors can answer practical business questions without hunting across multiple data sources.
Last refreshed 2026-04-23 | 33K search volume | Domain thermofisher.com
Thermo Fisher Scientific identity, aliases, ownership, and taxonomy
This section makes the entity easier to verify: canonical domains, alternate names, descriptions, ownership flags, parent or acquirer context, industry codes, and source-level social reach are grouped together.
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Thermo Fisher Scientific enables our customers to make the world healthier, cleaner and safer. Delivering technology, pharmaceutical and biotechnology services.
Thermo Fisher Scientific enables our customers to make the world healthier, cleaner and safer. Delivering technology, pharmaceutical and biotechnology services.
LinkedIn followers
2.3M
Latest linkedin followers value available from the source dataset.
Owler followers
5.2K
Latest owler followers value available from the source dataset.
Technologies detected
1.4K
Latest technologies detected value available from the source dataset.
Operating status
Active
Independent Company
Company type
Public Company
type
Ownership status
Public
Ownership Status
Public company
No
Is Public
Company alias
thermo fisher scientific
Company Name Alias
Company alias
clario
Company Name Alias
Company alias
thermo fisher scientific, inc.
Company Name Alias
Website alias
https://www.thermofisher.com
Website Alias
Website alias
https://www.thermofisher.com/
Website Alias
Website alias
https://www.thermofisher.com/clario
Website Alias
Canonical website
https://www.thermofisher.com
website
Website domain
thermofisher.com
Website Domain
Unique website
Yes
Unique Website
Unique domain
Yes
Unique Domain
Expired domain
No
Expired Domain
LinkedIn shorthand
thermo-fisher-scientific
Canonical LinkedIn Shorthand Name
Source ID
3081
Source ID
UUID
0TTSN8TS7MTBQPT9D16ZM8ZSWR
uuid
SIC code
38
SIC Codes
SIC code
382
SIC Codes
NAICS code
33
NAICS Codes
NAICS code
339
NAICS Codes
Industry
Biotechnology Research
industry
Categories and keywords
['biotechnology', 'analytical instruments', 'laboratory supply chain programs and ecommerce', 'laboratory equipment', 'lab services', 'specialty diagnostics', 'life sciences', 'pharma services', 'cdmo', 'cleaner', 'pharmaceutical', 'healthier', 'technology', 'health', 'biotech', 'life-sciences', 'medical-devices']
Categories And Keywords
LinkedIn followers
2.3M
Followers Count LinkedIn
Owler followers
5.2K
Followers Count Owler
Primary location
168 Third Avenue; Waltham, MA, US
Office location
168 Third Avenue; Waltham, Massachusetts, United States
Office location
168 Third Avenue; Waltham, 02451, United States
Office location
168 3rd Ave; Waltham, Massachusetts 02451, United States
Thermo Fisher Scientific revenue, funding, IPO, and acquisition history
Financial signals are grouped as an analyst-style view: revenue sources, income statement rows, funding rounds, acquisition activity, IPO fields, stock listing context, and ownership structure.
Source 5
$44.6B
Annual revenue
Stock ticker
TMO
NYSE
Operating status
Active
Independent Company
Company type
Public Company
type
Ownership status
Public
Ownership Status
Public company
No
Is Public
FY, 2025
Fiscal Year
Primary value
Revenue: $44.6B
Additional metrics
EBIT: $7.7B; Net income: $6.7B; Operating expense: $10.1B; EPS: 17.74
Q3, 2025
Q3
Primary value
Revenue: $11.1B
Additional metrics
Gross profit: $4.6B; EBIT: $1.9B; Net income: $1.6B; Operating expense: $2.6B; Gross margin: 41.2%; EPS: 4.27
Q2, 2025
Q2
Primary value
Revenue: $10.9B
Additional metrics
Gross profit: $4.4B; EBIT: $1.8B; Net income: $1.6B; Operating expense: $2.6B; Gross margin: 40.6%; EPS: 4.28
Q1, 2025
Q1
Primary value
Revenue: $10.4B
Additional metrics
Gross profit: $4.2B; EBIT: $1.7B; Net income: $1.5B; Operating expense: $2.5B; Gross margin: 40.9%; EPS: 3.98
Q1, 2025
Q1
Primary value
Revenue: $10.4B
Additional metrics
EBIT: $1.7B; Net income: $1.5B; Operating expense: $2.4B; EPS: 3.98
FY, 2024
Fiscal Year
Primary value
Revenue: $42.9B
Additional metrics
Gross profit: $17.7B; EBIT: $7.3B; Net income: $6.3B; Operating expense: $10.4B; Gross margin: 41.3%; EPS: 16.53
FY, 2024
Fiscal Year
Primary value
Revenue: $42.9B
Additional metrics
EBIT: $7.3B; Net income: $6.3B; Operating expense: $10B; EPS: 16.53
Q3, 2024
Q3
Primary value
Revenue: $10.6B
Additional metrics
Gross profit: $4.3B; EBIT: $1.8B; Net income: $1.6B; Operating expense: $2.5B; Gross margin: 40.8%; EPS: 4.25
Q2, 2024
Q2
Primary value
Revenue: $10.5B
Additional metrics
Gross profit: $4.3B; EBIT: $1.8B; Net income: $1.6B; Operating expense: $2.5B; Gross margin: 41.2%; EPS: 4.04
Q1, 2024
Q1
Primary value
Revenue: $10.3B
Additional metrics
Gross profit: $4.2B; EBIT: $1.7B; Net income: $1.3B; Operating expense: $2.5B; Gross margin: 40.6%; EPS: 3.46
FY, 2023
Fiscal Year
Primary value
Revenue: $42.9B
Additional metrics
Gross profit: $17.1B; EBIT: $6.9B; Net income: $6B; Operating expense: $10.2B; Gross margin: 39.9%; EPS: 15.45
Q3, 2023
Q3
Primary value
Revenue: $10.6B
Additional metrics
Gross profit: $4.3B; EBIT: $1.9B; Net income: $1.7B; Operating expense: $2.5B; Gross margin: 40.8%; EPS: 4.42
| Period | Primary value | Additional metrics |
|---|---|---|
FY, 2025 Fiscal Year | Revenue: $44.6B | EBIT: $7.7B; Net income: $6.7B; Operating expense: $10.1B; EPS: 17.74 |
Q3, 2025 Q3 | Revenue: $11.1B | Gross profit: $4.6B; EBIT: $1.9B; Net income: $1.6B; Operating expense: $2.6B; Gross margin: 41.2%; EPS: 4.27 |
Q2, 2025 Q2 | Revenue: $10.9B | Gross profit: $4.4B; EBIT: $1.8B; Net income: $1.6B; Operating expense: $2.6B; Gross margin: 40.6%; EPS: 4.28 |
Q1, 2025 Q1 | Revenue: $10.4B | Gross profit: $4.2B; EBIT: $1.7B; Net income: $1.5B; Operating expense: $2.5B; Gross margin: 40.9%; EPS: 3.98 |
Q1, 2025 Q1 | Revenue: $10.4B | EBIT: $1.7B; Net income: $1.5B; Operating expense: $2.4B; EPS: 3.98 |
FY, 2024 Fiscal Year | Revenue: $42.9B | Gross profit: $17.7B; EBIT: $7.3B; Net income: $6.3B; Operating expense: $10.4B; Gross margin: 41.3%; EPS: 16.53 |
FY, 2024 Fiscal Year | Revenue: $42.9B | EBIT: $7.3B; Net income: $6.3B; Operating expense: $10B; EPS: 16.53 |
Q3, 2024 Q3 | Revenue: $10.6B | Gross profit: $4.3B; EBIT: $1.8B; Net income: $1.6B; Operating expense: $2.5B; Gross margin: 40.8%; EPS: 4.25 |
Q2, 2024 Q2 | Revenue: $10.5B | Gross profit: $4.3B; EBIT: $1.8B; Net income: $1.6B; Operating expense: $2.5B; Gross margin: 41.2%; EPS: 4.04 |
Q1, 2024 Q1 | Revenue: $10.3B | Gross profit: $4.2B; EBIT: $1.7B; Net income: $1.3B; Operating expense: $2.5B; Gross margin: 40.6%; EPS: 3.46 |
FY, 2023 Fiscal Year | Revenue: $42.9B | Gross profit: $17.1B; EBIT: $6.9B; Net income: $6B; Operating expense: $10.2B; Gross margin: 39.9%; EPS: 15.45 |
Q3, 2023 Q3 | Revenue: $10.6B | Gross profit: $4.3B; EBIT: $1.9B; Net income: $1.7B; Operating expense: $2.5B; Gross margin: 40.8%; EPS: 4.42 |
Post-IPO Debt
$2.5B
2025-10-30
Post-IPO Debt
$3B
2023-08-07
Grant
$500K
2023-03-27 | National Grid
Post-IPO Debt
$1.3B
2022-11-15
Post-IPO Debt
$736.1M
2022-10-14
Post-IPO Debt
$6.1B
2021-10-06
Post-IPO Debt
Post-IPO Debt
Clario Holdings, Inc.
$8.9B
2025-10-01 | Acquisition List Source 5
Sanofi’s Steriles Manufacturing Site in Ridgefield, New Jersey
Acquisition
2025-07-01 | Acquisition List Source 5
Solventum Corporation's Purification and Filtration Business
$4.1B
2025-02-01 | Acquisition List Source 5
Olink Holding
$3.1B
2024-07-10 | Acquisition List Source 1
Olink Proteomics AB
$3.1B
2023-10-01 | Acquisition List Source 5
CorEvitas
$910M
2023-08-14 | Acquisition List Source 1
Corevitas, LLC
$912.5M
2023-07-01 | Acquisition List Source 5
MarqMetrix
Acquisition
2023-06-21 | Acquisition List Source 1
Marqmetrix, Inc.
Acquisition
2023-06-01 | Acquisition List Source 5
The Binding Site Group
$2.7B
2023-01-03 | Acquisition List Source 1
The Binding Site Group Ltd.
$2.6B
2022-10-01 | Acquisition List Source 5
Max Analytical Technologies
Acquisition
2022-03-01 | Acquisition List Source 5
PeproTech
$1.9B
2021-12-30 | Acquisition List Source 1
PPD
$16B
2021-12-08 | Acquisition List Source 1
PharmaFluidics
Acquisition
2021-12-08 | Acquisition List Source 1
Pharmaceutical Product Development
Acquisition
2021-12-08 | Acquisition List Source 1
PharmaFluidics
Acquisition
2021-11-01 | Acquisition List Source 1
Mesa Biotech
$472M
2021-02-25 | Acquisition List Source 1
Henogen
EUR 725M
2021-01-15 | Acquisition List Source 1
Phinotex
Acquisition
2020-12-31 | Acquisition List Source 1
QIAGEN
$11.5B
2020-03-03 | Acquisition List Source 1
HighChem
Acquisition
2019-06-06 | Acquisition List Source 1
Brammer Bio
$1.7B
2019-04-30 | Acquisition List Source 1
Becton Dickinson
$477M
2018-10-25 | Acquisition List Source 1
Gatan
$925M
2018-06-28 | Acquisition List Source 1
IntegenX
$65M
2018-03-16 | Acquisition List Source 1
Patheon
$7.4B
2017-08-29 | Acquisition List Source 1
Linkage Biosciences
Acquisition
2017-07-11 | Acquisition List Source 1
Patheon
$7.2B
2017-05-15 | Acquisition List Source 1
Core Informatics
$94M
2017-03-02 | Acquisition List Source 1
Finesse Solutions
$221M
2017-02-14 | Acquisition List Source 1
MTI-GlobalStem
Acquisition
2016-11-29 | Acquisition List Source 1
FEI
$4.1B
2016-09-19 | Acquisition List Source 1
Affymetrix
$1.3B
2016-03-31 | Acquisition List Source 1
Inel
Acquisition
2016-02-12 | Acquisition List Source 1
Alfa Aesar
GBP 257M
2015-09-30 | Acquisition List Source 1
Advanced Scientifics
$289M
2015-02-05 | Acquisition List Source 1
Prionics
Acquisition
2014-03-17 | Acquisition List Source 1
Life Technologies
$15.3B
2014-02-03 | Acquisition List Source 1
picoSpin
Acquisition
2012-12-21 | Acquisition List Source 1
One Lambda
$885M
2012-09-13 | Acquisition List Source 1
Princeton Security Technologies
$12.9M
2012-07-24 | Acquisition List Source 1
Doe & Ingalls
$178M
2012-05-01 | Acquisition List Source 1
Intrinsic Bioprobes
Acquisition
2011-09-02 | Acquisition List Source 1
Phadia
$3.5B
2011-08-23 | Acquisition List Source 1
Trek Diagnostic Systems
Acquisition
2011-07-18 | Acquisition List Source 1
Sterilin
Acquisition
2011-05-18 | Acquisition List Source 1
Dionex
$2B
2011-05-17 | Acquisition List Source 1
TKA Wasseraufbereitungssysteme
Acquisition
2011-01-05 | Acquisition List Source 1
Lomb Scientific
Acquisition
2010-12-27 | Acquisition List Source 1
Fermentas International
$260M
2010-07-16 | Acquisition List Source 1
Polychromix
Acquisition
2010-06-10 | Acquisition List Source 1
Proxeon
Acquisition
2010-04-15 | Acquisition List Source 1
Finnzymes
$58M
2010-03-05 | Acquisition List Source 1
Ahura Scientific
$147M
2010-02-26 | Acquisition List Source 1
NovaWave Technologies
Acquisition
2010-02-08 | Acquisition List Source 1
B.R.A.H.M.S.
$482M
2009-10-01 | Acquisition List Source 1
Biolab
$132M
2009-04-27 | Acquisition List Source 1
ABR--Affinity BioReagents
Acquisition
2008-07-17 | Acquisition List Source 1
La-Pha-Pack
$50M
2007-12-28 | Acquisition List Source 1
NanoDrop Technologies
$156M
2007-10-10 | Acquisition List Source 1
Priority Solutions International
$164M
2007-10-03 | Acquisition List Source 1
Flux Instruments
Acquisition
2007-01-17 | Acquisition List Source 1
Spectronex
Acquisition
2007-01-17 | Acquisition List Source 1
SwissAnalytic Group
Acquisition
2007-01-15 | Acquisition List Source 1
Cohesive Technologies
$70.2M
2006-12-14 | Acquisition List Source 1
EGS Gauging
$28.4M
2006-06-30 | Acquisition List Source 1
Omega Data Systems
Acquisition
2006-06-28 | Acquisition List Source 1
Fisher BioImage ApS
Acquisition
2006-05-03 | Acquisition List Source 1
Clintrak
$125M
2006-04-11 | Acquisition List Source 1
Ionalytics Corporation
$24.7M
2005-08-11 | Acquisition List Source 1
Kendro Laboratory Products
$837.1M
2005-05-09 | Acquisition List Source 1
Rupprecht and Patashnick
$31M
2005-04-27 | Acquisition List Source 1
Niton
$43M
2005-03-29 | Acquisition List Source 1
InnaPhase Corporation
$64.7M
2004-09-15 | Acquisition List Source 1
US Counseling Services
$74.7M
2004-04-30 | Acquisition List Source 1
Oxoid
$330M
2004-02-11 | Acquisition List Source 1
Dharmacon
$80M
2004-01-04 | Acquisition List Source 1
Jouan SA
EUR 110.9M
2003-12-31 | Acquisition List Source 1
Perbio Science
Acquisition
2003-06-26 | Acquisition List Source 1
CRS Robotics
Acquisition
2002-04-29 | Acquisition List Source 1
Thermo Hypersil-Keystone
Acquisition
2000-07-12 | Acquisition List Source 1
Keystone Scientific
Acquisition
2000-07-10 | Acquisition List Source 1
Kendro Containment & Services Limited
Acquisition
Acquisition List Source 1
Thermo Fisher (China) Analytical Ltd.
Acquisition
Acquisition List Source 1
Thermo Fisher Investments (Cayman) LLC
Acquisition
Acquisition List Source 1
Patheon France SAS
Acquisition
Acquisition List Source 1
The Binding Site Holding GmbH
Acquisition
Acquisition List Source 1
Remel Inc.
Acquisition
Acquisition List Source 1
Life Technologies Europe B.V.
Acquisition
Acquisition List Source 1
Thermo Fisher Scientific GCL Limited
Acquisition
Acquisition List Source 1
Oncomine Molecular Inc.
Acquisition
Acquisition List Source 1
Gold Cattle Standard Testing Labs, Inc.
Acquisition
Acquisition List Source 1
FSWH International Holdings LLC
Acquisition
Acquisition List Source 1
NAPCO, Inc.
Acquisition
Acquisition List Source 1
Thermo Fisher Scientific Life Sciences COE Corporation
Acquisition
Acquisition List Source 1
PeproTech, Inc.
Acquisition
Acquisition List Source 1
Dionex Canada Ltd.
Acquisition
Acquisition List Source 1
Thermo Finland Holdings MT1 B.V.
Acquisition
Acquisition List Source 1
Finesse Scientific Equipment (Shanghai) Co., Ltd.
Acquisition
Acquisition List Source 1
Thermo Fisher Scientific China Holdings II B.V.
Acquisition
Acquisition List Source 1
Thermo Fisher Scientific Aquasensors LLC
Acquisition
Acquisition List Source 1
Life Technologies Co., Ltd.
Acquisition
Acquisition List Source 1
Patheon Biologics B.V.
Acquisition
Acquisition List Source 1
Brammer Bio Holding Company, LLC
Acquisition
Acquisition List Source 1
Fisher Emergo B.V.
Acquisition
Acquisition List Source 1
Synexus Ukraine Limited Liability Company
Acquisition
Acquisition List Source 1
Thermo Fisher Scientific South Africa Proprietary Ltd
Acquisition
Acquisition List Source 1
Web visibility, demand, and topics
Use these signals to understand discoverability, demand quality, search interest, and audience fit.
Monthly visits
5.6M
Latest monthly visits value available from the source dataset.
Global web rank
#9,461
Lower rank values indicate stronger web visibility in the source dataset.
Bounce rate
46.0%
Latest bounce rate value available from the source dataset.
Pages per visit
4.11
Latest pages per visit value available from the source dataset.
Average visit duration
4m 34s
Latest average visit duration value available from the source dataset.
Estimated monthly page views
22.8M
Derived estimate calculated as monthly visits multiplied by pages per visit.
thermo fisher scientific
Associated search topic
thermo fisher
Associated search topic
thermofisher
Associated search topic
thermo fisher careers
Associated search topic
thermo fisher scientific careers
Associated search topic
LinkedIn followers
2.3M
Followers Count LinkedIn
Owler followers
5.2K
Followers Count Owler
Employees, hiring, attrition, and compensation
This section groups org scale, hiring motion, employee movement, department mix, and salary benchmarks so teams can qualify operating momentum and budget signals.
Employees
99.9K
Latest employees value available from the source dataset.
Inferred employees
55.8K
Latest inferred employees value available from the source dataset.
Open roles
3.8K
Latest open roles value available from the source dataset.
Departures
0
Latest departures value available from the source dataset.
Employee attrition rate
0.0%
Latest employee attrition rate value available from the source dataset.
Hiring intensity
37.7 roles / 1K employees
Derived signal showing open roles normalized by employee count.
Key Account Manager ANZ - Microbiology
Open role
4312000399
Key Account Manager ANZ - Microbiology
Open role
4340071631
Staff Medical Device Autoinjector Engineer
Open role
4348640604
Sr. Director, Organizational Design and Effectiveness
Open role
4352054582
Manager, Validation
Open role
4354093706
CRA (Level II)
Open role
4360562381
Manufacturing Operations Supervisor
Open role
4361460992
Assistant CRA (m/f/d) (Open)
Open role
4363013709
Showing 8 of 18 available records.
Showing 8 of 10 available records.
Showing 8 of 10 available records.
Product readiness, customer proof, and employee sentiment
Product availability, public reviews, and employee sentiment help visitors understand whether the company is mature, documented, reviewable, and operationally healthy.
Employee reviews
585
Latest employee reviews value available from the source dataset.
Employee rating
3.5
Latest review score available from the source dataset.
Is pricing information available?
Yes. The source snapshot lists pricing information for this company.
Source availability signal
Is a free trial listed?
No. The source snapshot does not list a free trial for this company.
Source availability signal
Can buyers request a demo?
No. The source snapshot does not list a demo motion for this company.
Source availability signal
Is the product downloadable?
No. The source snapshot does not list downloadable software for this company.
Source availability signal
Are mobile apps listed?
No. The source snapshot does not list mobile apps for this company.
Source availability signal
Is public documentation listed?
No. The source snapshot does not list public documentation for this company.
Source availability signal
Are online reviews listed?
No. The source snapshot does not list online reviews for this company.
Source availability signal
Technology, leadership, competitors, funding, and corporate activity
These data points help sales, partnerships, analysts, and researchers understand how the company operates, who surrounds it, and where it may be moving next.
Forecast Pro
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Taleo
Verified technology
Last verified 2026-05-04 | First seen 2024-11-18
Endnote
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Source Intelligence
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Ensighten
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Oracle Soa
Verified technology
Last verified 2026-05-04 | First seen 2024-08-05
Graphpad Prism
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Windows Server 2012
Verified technology
Last verified 2026-05-04 | First seen 2025-02-18
Showing 8 of 24 available records.
Showing 8 of 12 available records.
Paolo Suffianò
Site Materials Leader
Allison Heck
Vice President, Head Of CorEvitas
Elena Arvaniti
Director RWE, Strategic Business Operations Data Analytics
Martin Ruehl
Director, HPLC Product Management
Adam N.
Director, Data Platforms & Intelligent Systems
Adan Castillo
Director Project Management
Marijke Van Gruijthuijsen
Clinical Systems Optimization Director
Frank Bella
Associate Director - Service
Showing 8 of 12 available records.
Cheri Prather
Executive Account Director, Business Development
Mar 2026
Pernille Blach Moen
Local Study Associate Director
Apr 2026
Jessica Lewis
Senior Account Director, Business Development
Mar 2026
Joe Groppenbacher
Sr. Sales Director, North America, Lab Chemicals and Consumables
Jan 2026
Gabriela Greenland
Medical Director - MSERM
Apr 2026
Jonathon Sheldon
Director of Technical Operations
Dec 2025
Dehuel Perez Viera
Director
Mar 2026
Collin O.
Director, Strategic Initiatives - Product Cost Innovation
Mar 2026
DjoDjo Amorin
Supplier Quality Engineer
Apr 2026
Jim Kutchel
Director, Supply Chain Logistics
Jan 2026
Caroline Delaitre-Bonnin
Executive Director, Lead of Access Strategy, PPD Evidera Health Economics and Market Access
Apr 2026
John Bishop
Director of R&D, Microarray Business Unit, Genetic Sciences Division
Dec 2025
Luke Hicks
Sr Procurement Partner, Biologics
Jan 2026
Carmen Chin
Head, Manufacturing Sciences and Technology
Mar 2026
Rich Monahan
Director, Operations Finance - CMD
Dec 2025
Rob Foley MBA-MSIS
Director, Global Talent Management
Dec 2025
Primary location
168 Third Avenue; Waltham, MA, US
Office location
168 Third Avenue; Waltham, Massachusetts, United States
Office location
168 Third Avenue; Waltham, 02451, United States
Office location
168 3rd Ave; Waltham, Massachusetts 02451, United States
A folded piece of paper that can hold more than 10,000 times its own weight. A big idea to help people affect…
59 reactions; 1 comments
2026-04-20 | A folded piece of paper that can hold more than 10,000 times its own weight. A big idea to help people affected by natural disasters. On The Kelly Clarkson Show, 14-year-old Miles Wu shared how he used origami and engi…
A biobank is more than a storage facility. It is part of the foundation for precision medicine. As highlight…
302 reactions; 20 comments
2026-04-16 | A biobank is more than a storage facility. It is part of the foundation for precision medicine. As highlighted in Inside Precision Medicine, biobanks can help researchers connect patient samples with clinical and molec…
A new picture of coastal life is coming into focus. In this edition of Serving Science, we follow the TREC e…
314 reactions; 5 comments
2026-04-15 | A new picture of coastal life is coming into focus. In this edition of Serving Science, we follow the TREC expedition as researchers travel Europe’s coastline to study ecosystems in real time, using mobile labs and adv…
Using the International Space Station as a laboratory is helping scientists accelerate research into neurodeg…
382 reactions; 14 comments
2026-04-14 | Using the International Space Station as a laboratory is helping scientists accelerate research into neurodegenerative diseases such as Alzheimer’s disease. Early findings from a team at UC San Diego suggest that 30 da…
Seeing disease more clearly can change how therapies are discovered. At our new Cryo-Electron Microscopy (cr…
896 reactions; 20 comments
2026-04-13 | Seeing disease more clearly can change how therapies are discovered. At our new Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center in South San Francisco, customers can access near-atomic views of proteins earlie…
The future of precision medicine will be shaped by the quality, scale, and depth of the biological insights w…
595 reactions; 10 comments
2026-04-10 | The future of precision medicine will be shaped by the quality, scale, and depth of the biological insights we can generate today. That is why biobanking and proteomics matter so much. Large, longitudinal population s…
SIC code
38
SIC Codes
SIC code
382
SIC Codes
NAICS code
33
NAICS Codes
NAICS code
339
NAICS Codes
Industry
Biotechnology Research
industry
Categories and keywords
['biotechnology', 'analytical instruments', 'laboratory supply chain programs and ecommerce', 'laboratory equipment', 'lab services', 'specialty diagnostics', 'life sciences', 'pharma services', 'cdmo', 'cleaner', 'pharmaceutical', 'healthier', 'technology', 'health', 'biotech', 'life-sciences', 'medical-devices']
Categories And Keywords
Thermo Fisher Scientific FAQs
Company profile
Want verified contact data for Thermo Fisher Scientific?
Datakart.ai gives you verified email addresses, direct dials, and buying intent signals for key decision-makers at Thermo Fisher Scientific and 1,700+ other companies.